Illinois Municipal Retirement Fund Cuts Stake in Integer Holdings Co. (NYSE:ITGR)

Illinois Municipal Retirement Fund lowered its position in shares of Integer Holdings Co. (NYSE:ITGR) by 2.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,712 shares of the medical equipment provider’s stock after selling 452 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Integer were worth $1,953,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Blue Trust Inc. increased its holdings in shares of Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 377 shares in the last quarter. Emerald Mutual Fund Advisers Trust increased its holdings in shares of Integer by 66.6% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 1,461 shares of the medical equipment provider’s stock valued at $115,000 after purchasing an additional 584 shares in the last quarter. Strs Ohio increased its holdings in shares of Integer by 54.5% in the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock valued at $168,000 after purchasing an additional 600 shares in the last quarter. Van ECK Associates Corp increased its holdings in shares of Integer by 22.0% in the 3rd quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider’s stock valued at $136,000 after purchasing an additional 313 shares in the last quarter. Finally, Mackenzie Financial Corp purchased a new position in shares of Integer in the 4th quarter valued at about $204,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Price Performance

Integer stock opened at $111.25 on Friday. The firm’s 50-day moving average is $112.91 and its two-hundred day moving average is $99.57. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.80 and a quick ratio of 1.71. Integer Holdings Co. has a 12-month low of $69.40 and a 12-month high of $123.99. The stock has a market capitalization of $3.73 billion, a P/E ratio of 41.36, a P/E/G ratio of 1.71 and a beta of 1.10.

Integer (NYSE:ITGR) last released its earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.05. Integer had a net margin of 5.68% and a return on equity of 10.80%. The business had revenue of $413.15 million for the quarter, compared to analysts’ expectations of $409.04 million. During the same period last year, the company earned $1.11 earnings per share. The company’s quarterly revenue was up 10.9% on a year-over-year basis. Equities analysts predict that Integer Holdings Co. will post 5.31 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on ITGR shares. KeyCorp increased their price target on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th. Benchmark raised their target price on shares of Integer from $105.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, March 28th. Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and raised their target price for the company from $105.00 to $135.00 in a report on Monday, April 15th. Finally, CL King started coverage on shares of Integer in a report on Thursday, March 14th. They set a “buy” rating and a $137.00 target price for the company. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and an average price target of $120.50.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.